Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Active not recruiting 3Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Melanoma 24Carcinoma, Non-Small-Cell Lung 24Stomach Neoplasms 9Neoplasms 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Hodgkin Disease 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Uveal Melanoma 2Small Cell Lung Carcinoma 2Sarcoma 2Recurrence 2Mesothelioma, Malignant 2Lymphoma, B-Cell 2Leukemia, Myeloid, Acute 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Carcinoma 2Brain Neoplasms 2

Interventions

Methotrexate 5Drug Therapy 5apatinib 4Neoadjuvant Therapy 4Doxorubicin 3camrelizumab 2Ifosfamide 2Cisplatin 2trilaciclib 1spartalizumab 1palbociclib 1isophosphamide mustard 1irinotecan sucrosofate 1glucarpidase 1endostar protein 1Zoledronic Acid 1Vinorelbine 1Triptorelin Pamoate 1Trabectedin 1Therapeutics 1Thalidomide 1TQ-B3525 1Psychiatric Rehabilitation 1Nivolumab 1Neuropsychological Tests 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Microbiota 1Metabolome 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Osteosarcoma × Nivolumab × Clear all
NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
60 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡